JP2002531548A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002531548A5 JP2002531548A5 JP2000586691A JP2000586691A JP2002531548A5 JP 2002531548 A5 JP2002531548 A5 JP 2002531548A5 JP 2000586691 A JP2000586691 A JP 2000586691A JP 2000586691 A JP2000586691 A JP 2000586691A JP 2002531548 A5 JP2002531548 A5 JP 2002531548A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- methyl
- methylsulfinyl
- carbamoyl
- methoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 Cc1ccc(*)cc1S(C)=O Chemical compound Cc1ccc(*)cc1S(C)=O 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9826941.8A GB9826941D0 (en) | 1998-12-09 | 1998-12-09 | Compounds |
| GB9826941.8 | 1998-12-09 | ||
| PCT/GB1999/004118 WO2000034243A1 (en) | 1998-12-09 | 1999-12-06 | N-(2-phenyl-4-piperidinybutyl)-5,6,7,8-tetrahydro-1-naphthalenecarboxamides and their use as neurokinin 1 (nk1) and/or neurokinin 2 (nk2) receptor antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002531548A JP2002531548A (ja) | 2002-09-24 |
| JP2002531548A5 true JP2002531548A5 (https=) | 2007-01-25 |
Family
ID=10843818
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000586691A Pending JP2002531548A (ja) | 1998-12-09 | 1999-12-06 | Ｎ−（２−フェニルー４−ピペリジニルブチル）−５，６，７，８−テトラヒドロー１−ナフタレンカルボキサミド、およびニューロキニン１（ｎｋ１）および／またはニューロキニン２（ｎｋ２）リセプター拮抗薬としてのそれらの使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6403601B1 (https=) |
| EP (1) | EP1137637A1 (https=) |
| JP (1) | JP2002531548A (https=) |
| AU (1) | AU1667500A (https=) |
| GB (1) | GB9826941D0 (https=) |
| WO (1) | WO2000034243A1 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6898636B1 (en) * | 1999-02-04 | 2005-05-24 | Intralinks, Inc. | Methods and systems for interchanging documents between a sender computer, a server and a receiver computer |
| GB9911017D0 (en) * | 1999-05-13 | 1999-07-14 | Zeneca Ltd | Pharmaceutical compositions |
| US6846814B2 (en) | 2000-04-06 | 2005-01-25 | Astra Zeneca Ab | Neurokinin antagonists for use as medicaments |
| US6903092B2 (en) | 2000-04-06 | 2005-06-07 | Peter Bernstein | Naphthamide neurokinin antagonists for use as medicaments |
| EP1278719B1 (en) * | 2000-04-06 | 2005-11-02 | AstraZeneca AB | Naphthamide neurokinin antagonists for use as medicaments |
| DE60134735D1 (de) * | 2000-04-06 | 2008-08-21 | Astrazeneca Ab | Neue neurokinin-antagonisten zum gebrauch als arzneimittel |
| GB0015246D0 (en) * | 2000-06-22 | 2000-08-16 | Astrazeneca Ab | Method for the treatment of urinary incontinence |
| SE0103795D0 (sv) | 2001-11-02 | 2001-11-02 | Astrazeneca Ab | Compounds and method for the treatment of överactive bladder |
| SE0103668D0 (sv) * | 2001-11-02 | 2001-11-02 | Astrazeneca Ab | Method for the treatment of overactive blader |
| TW200508221A (en) | 2003-06-13 | 2005-03-01 | Astrazeneca Ab | New azetidine compounds |
| US20040265238A1 (en) | 2003-06-27 | 2004-12-30 | Imtiaz Chaudry | Inhalable formulations for treating pulmonary hypertension and methods of using same |
| GB0418045D0 (en) | 2004-08-12 | 2004-09-15 | Glaxo Group Ltd | Compounds |
| SE0403005D0 (sv) * | 2004-12-09 | 2004-12-09 | Astrazeneca Ab | New use |
| AR056087A1 (es) * | 2005-09-29 | 2007-09-19 | Astrazeneca Ab | Derivados de azetidina como antagonistas de receptores de neuroquina nk |
| AR057828A1 (es) | 2005-09-29 | 2007-12-19 | Astrazeneca Ab | Compuestos derivados de azetidina, su preparacion y composicion farmaceuutica |
| US8106208B2 (en) | 2006-05-18 | 2012-01-31 | Albireo Ab | Benzamide compounds that act as NK receptor antagonists |
| EP2117538A1 (en) | 2007-01-24 | 2009-11-18 | Glaxo Group Limited | Pharmaceutical compositions comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-) |
| JP2026500298A (ja) | 2022-12-15 | 2026-01-06 | シンジェンタ クロップ プロテクション アクチェンゲゼルシャフト | 殺有害生物剤として有用である新規な二環式カルボキサミド化合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL99320A (en) * | 1990-09-05 | 1995-07-31 | Sanofi Sa | Arylalkylamines, their preparation and pharmaceutical compositions containing them |
| GB9310066D0 (en) * | 1993-05-17 | 1993-06-30 | Zeneca Ltd | Alkyl substituted heterocycles |
| GB9310713D0 (en) | 1993-05-24 | 1993-07-07 | Zeneca Ltd | Aryl substituted heterocycles |
| GB9617730D0 (en) * | 1996-08-23 | 1996-10-02 | Pfizer Ltd | Quarternary ammonium compounds |
| US5789422A (en) * | 1996-10-28 | 1998-08-04 | Schering Corporation | Substituted arylalkylamines as neurokinin antagonists |
-
1998
- 1998-12-09 GB GBGB9826941.8A patent/GB9826941D0/en not_active Ceased
-
1999
- 1999-12-06 WO PCT/GB1999/004118 patent/WO2000034243A1/en not_active Ceased
- 1999-12-06 US US09/857,833 patent/US6403601B1/en not_active Expired - Fee Related
- 1999-12-06 AU AU16675/00A patent/AU1667500A/en not_active Abandoned
- 1999-12-06 JP JP2000586691A patent/JP2002531548A/ja active Pending
- 1999-12-06 EP EP99959534A patent/EP1137637A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002531548A5 (https=) | ||
| JP2002520316A5 (https=) | ||
| JP2004517087A5 (https=) | ||
| JP2005536475A5 (https=) | ||
| JP2004517049A5 (https=) | ||
| JP2007533741A5 (ja) | Ｂａｃｅ阻害剤として有用なピロリジン誘導体 | |
| JP2011504497A5 (https=) | ||
| JP2006518728A5 (https=) | ||
| JP2004525179A5 (https=) | ||
| RU2000126841A (ru) | Производные амида и антагонисты ноцицептина | |
| JP2003525279A5 (https=) | ||
| JP2001526218A5 (https=) | ||
| JP2009528296A5 (https=) | ||
| JP2009523760A5 (https=) | ||
| JP2006503019A5 (https=) | ||
| JP2013521286A5 (https=) | ||
| JP2012501313A5 (https=) | ||
| RU2002121646A (ru) | 1,3-дизамещенные пирролидины в качестве антагонистов альфа-2-адренорецепторов | |
| JP2007182422A5 (https=) | ||
| WO2004013100A3 (fr) | Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique | |
| JP2004524299A5 (https=) | ||
| JP2002526410A5 (https=) | ||
| JP2007515467A5 (https=) | ||
| JP2006516626A5 (https=) | ||
| JP2004525178A5 (https=) |